These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 10817750

  • 1. Effect of oral administration of emtricitabine on woodchuck hepatitis virus replication in chronically infected woodchucks.
    Korba BE, Schinazi RF, Cote P, Tennant BC, Gerin JL.
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1757-60. PubMed ID: 10817750
    [Abstract] [Full Text] [Related]

  • 2. Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S, Butler SD, George AL, Tochkov IA, Zhu Y, Xiong S, Gerin JL, Cote PJ, Tennant BC.
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3617-32. PubMed ID: 18676881
    [Abstract] [Full Text] [Related]

  • 3. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S, Cote PJ, Korba BE, Butler SD, George AL, Tochkov IA, Delaney WE, Xiong S, Gerin JL, Tennant BC.
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [Abstract] [Full Text] [Related]

  • 4. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF, Cote PJ, Jacob JR, Toshkov IA, Hornbuckle WE, Baldwin BH, Wells FV, Chu CK, Gerin JL, Tennant BC, Korba BE.
    Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
    [Abstract] [Full Text] [Related]

  • 5. Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.
    Jacquard AC, Nassal M, Pichoud C, Ren S, Schultz U, Guerret S, Chevallier M, Werle B, Peyrol S, Jamard C, Rimsky LT, Trepo C, Zoulim F.
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2683-92. PubMed ID: 15215126
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
    Korba BE, Cote P, Hornbuckle W, Schinazi R, Gangemi JD, Tennant BC, Gerin JL.
    Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
    [Abstract] [Full Text] [Related]

  • 9. Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B.
    Michalak TI, Zhang H, Churchill ND, Larsson T, Johansson NG, Oberg B.
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3803-14. PubMed ID: 19564357
    [Abstract] [Full Text] [Related]

  • 10. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
    Le Guerhier F, Pichoud C, Jamard C, Guerret S, Chevallier M, Peyrol S, Hantz O, King I, Trépo C, Cheng YC, Zoulim F.
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1065-77. PubMed ID: 11257017
    [Abstract] [Full Text] [Related]

  • 11. Viral pharmacodynamic model for (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine (emtricitabine) in chronically infected woodchucks.
    Hurwitz SJ, Tennant BC, Korba BE, Liberman I, Gerin JL, Schinazi RF.
    Antivir Chem Chemother; 2002 May; 13(3):165-76. PubMed ID: 12448689
    [Abstract] [Full Text] [Related]

  • 12. Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks.
    Korolowicz KE, Suresh M, Li B, Huang X, Yon C, Kallakury BV, Lee KP, Park S, Kim YW, Menne S.
    Cells; 2021 Sep 05; 10(9):. PubMed ID: 34571970
    [Abstract] [Full Text] [Related]

  • 13. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S, Asif G, Narayanasamy J, Butler SD, George AL, Hurwitz SJ, Schinazi RF, Chu CK, Cote PJ, Gerin JL, Tennant BC.
    Antimicrob Agents Chemother; 2007 Sep 05; 51(9):3177-84. PubMed ID: 17606676
    [Abstract] [Full Text] [Related]

  • 14. Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
    Daffis S, Balsitis S, Chamberlain J, Zheng J, Santos R, Rowe W, Ramakrishnan D, Pattabiraman D, Spurlock S, Chu R, Kang D, Mish M, Ramirez R, Li L, Li B, Ma S, Hung M, Voitenleitner C, Yon C, Suresh M, Menne S, Cote P, Delaney WE, Mackman R, Fletcher SP.
    Hepatology; 2021 Jan 05; 73(1):53-67. PubMed ID: 32246499
    [Abstract] [Full Text] [Related]

  • 15. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
    Korba BE, Cote P, Hornbuckle W, Schinazi R, Gerin JL, Tennant BC.
    Antiviral Res; 2000 Jan 05; 45(1):19-32. PubMed ID: 10774587
    [Abstract] [Full Text] [Related]

  • 16. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
    Lu M, Hilken G, Yang D, Kemper T, Roggendorf M.
    J Virol; 2001 Apr 05; 75(8):3811-8. PubMed ID: 11264370
    [Abstract] [Full Text] [Related]

  • 17. Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.
    Menne S, Tumas DB, Liu KH, Thampi L, AlDeghaither D, Baldwin BH, Bellezza CA, Cote PJ, Zheng J, Halcomb R, Fosdick A, Fletcher SP, Daffis S, Li L, Yue P, Wolfgang GH, Tennant BC.
    J Hepatol; 2015 Jun 05; 62(6):1237-45. PubMed ID: 25559326
    [Abstract] [Full Text] [Related]

  • 18. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
    Suresh M, Li B, Huang X, Korolowicz KE, Murreddu MG, Gudima SO, Menne S.
    Front Immunol; 2021 Jun 05; 12():745802. PubMed ID: 34671360
    [Abstract] [Full Text] [Related]

  • 19. T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.
    Hervás-Stubbs S, Lasarte JJ, Sarobe P, Vivas I, Condreay L, Cullen JM, Prieto J, Borrás-Cuesta F.
    J Hepatol; 2001 Jul 05; 35(1):105-11. PubMed ID: 11495027
    [Abstract] [Full Text] [Related]

  • 20. Efficiency of oxetanocin-G, a novel nucleoside against the woodchuck hepatitis virus.
    Ikeda N, Kaneko S, Shimoda A, Inagaki Y, Unoura M, Okada M, Yonekawa Y, Takahashi K, Kobayashi K.
    J Antimicrob Chemother; 1994 Jan 05; 33(1):83-9. PubMed ID: 8157578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.